Evidence & policy library
Every pathway is linked to the organizations responsible for the decision.
17 source records
Methodology
Pathway information draws on official regulator, HTA and payer materials. Consult the cited policy for its conditions and effective date, and see Content & use for guidance on applying Atlas to your research.
Matching documents: 29
Market / scopeOfficial evidence recordTypePolicy / reference dateLast checked
Europe
🇧🇪 BelgiumOfficialMA/temporary use, CUP/MNP, supplycurrent frameworkLatest observed: program/list current Jul 2026
🇧🇪 BelgiumOfficialMA/temporary use, CUP/MNP, supplycurrent frameworkLatest observed: program/list current Jul 2026
🇧🇪 BelgiumOfficialMA/temporary use, CUP/MNP, supplycurrent frameworkLatest observed: program/list current Jul 2026
🇧🇪 BelgiumOfficialsame-day filing, 90/180 days, maximum pricecurrentLatest observed: checked 2026
🇧🇪 BelgiumOfficialsame-day filing, 90/180 days, maximum pricecurrentLatest observed: checked 2026
🇧🇪 BelgiumOfficialdossier, evaluation, Minister, publication, reviewAR 2018/currentLatest observed: current 2026
🇧🇪 BelgiumOfficialdossier, evaluation, Minister, publication, reviewAR 2018/currentLatest observed: current 2026
🇧🇪 BelgiumOfficial180-day clock, conditions, adviser/collegecurrentLatest observed: checked 2026
🇧🇪 BelgiumOfficialpatient input/governanceeffective 2025-04-01Latest observed: 2025
🇧🇪 BelgiumOfficialtemporary reimbursement, evidence, compensation, confidentiality/exitcurrentLatest observed: MORSE 2026
🇧🇪 BelgiumOfficialtemporary reimbursement, evidence, compensation, confidentiality/exitcurrentLatest observed: MORSE 2026
🇧🇪 BelgiumOfficialEarly/Fast eligibility, framework, patient interventioneffective 2026-03-01Latest observed: current Jul 2026
🇧🇪 BelgiumOfficialEarly/Fast eligibility, framework, patient interventioneffective 2026-03-01Latest observed: current Jul 2026
🇧🇪 BelgiumOfficialchapter purpose, prior/post control, biomarker linkagecurrentLatest observed: checked 2026
🇧🇪 BelgiumOfficialA–Fb, patient/hospital sharescurrent 2026Latest observed: 2026
🇧🇪 BelgiumOfficialA–Fb, patient/hospital sharescurrent 2026Latest observed: 2026
🇧🇪 BelgiumOfficialAPR-DRG forfait and high-cost exclusionssince 2006; update 2024Latest observed: monthly current 2026
🇧🇪 BelgiumOfficialBMF excludes pharmaceuticalscurrent hospital frameworkLatest observed: BMF 2026
🇧🇪 BelgiumOfficial78% billing, hospital absorption, reference/biosimilar lifecycleeffective 2026-01-01Latest observed: 2026
🇧🇪 BelgiumOfficialeffective vs future reform milestonesroadmap 2023–27Latest observed: current 2026
🇧🇪 BelgiumOfficialoperational chapter/category/temp statusmonthlyLatest observed: Jul 2026
🇧🇪 BelgiumOfficialoperational chapter/category/temp statusmonthlyLatest observed: Jul 2026
🇧🇪 BelgiumOfficialscope declaration, parallel notification, product-specific upload and submission-date changes2026-08-19Latest observed: 2026-09-02
🇧🇪 BelgiumOfficialscope declaration, parallel notification, product-specific upload and submission-date changes2026-08-19Latest observed: 2026-09-02
🇧🇪 BelgiumOfficialscope declaration, parallel notification, product-specific upload and submission-date changes2026-08-19Latest observed: 2026-09-02
🇧🇪 BelgiumOfficialvoluntary participation, initial-application window, readiness dialogue and Letter of Intent milestones2026-08-28Latest observed: 2026-09-07
🇧🇪 BelgiumOfficialvoluntary participation, initial-application window, readiness dialogue and Letter of Intent milestones2026-08-28Latest observed: 2026-09-07
🇧🇪 BelgiumOfficialEU-level pre-JCA request window, product eligibility, platform deadline and national-reimbursement boundary2025-11-28 annual programme; 2026-09-22 announcementLatest observed: 2026-09-22
🇧🇪 BelgiumOfficialEU-level pre-JCA request window, product eligibility, platform deadline and national-reimbursement boundary2025-11-28 annual programme; 2026-09-22 announcementLatest observed: 2026-09-22
For education only — not regulatory, pricing or legal advice.